The Role of Oncology Nurse Practitioners in Metastatic Triple-Negative Breast Cancer Care

This video was supported by Gilead Sciences, Inc., but editorially independently created by the Oncology Nursing News team.

NP Theresa Stukus and NP Nelli Zafman discuss the expanding role of oncology nurse practitioners and advanced practice providers in delivering comprehensive care for patients with metastatic triple-negative breast cancer (mTNBC). The faculty highlights how APPs help patients navigate increasingly complex frontline treatment decisions by integrating clinical factors, biomarker results, comorbidities, and individual lifestyle considerations into shared decision-making. They emphasize that patient education begins before treatment initiation and continues throughout therapy, with a strong focus on setting expectations for potential adverse events, reinforcing symptom recognition, and encouraging early communication with the care team. NP Stukus and NP Zafman also discuss proactive toxicity monitoring and timely intervention as essential strategies for minimizing treatment-related complications, preserving quality of life, and helping patients remain on therapy whenever appropriate. Throughout the discussion, they underscore the critical role of APPs in coordinating multidisciplinary care and supporting patients across every stage of the metastatic triple-negative breast cancer treatment journey.